Menu

Moderna MRNA

High: Low:

Moderna, Inc. Biotechnology company focused on the discovery and development of drugs based on messenger RNA. Based in Massachussets. Yahoo! Finance

Traders' Sentiments

% Buyers % Sellers

Info

Moderna, Inc. Biotechnology company focused on the discovery and development of drugs based on messenger RNA. Based in Massachussets. Yahoo! Finance

Spread 2.62 Spread (%) 0.75%
Overnight funding - Buy -0.0552% Overnight funding - Sell -0.0546%
Initial margin 100.00% Maintenance margin 50.00%
Leverage 1:1 Expires daily No

Related Instruments

Name Sell Sell button / Change  Buy     Change Change Change Change Change Change
{{item.Name}} {{item.SellPrice}} Sell Buy {{item.ChangePercentText}} Trade

Plus500 News & Market Insights

Moderna Hits Record Price as Delta Variant Spreads
Plus500
Aug 10 2021

Moderna Hits Record Price as Delta Variant Spreads

Moderna stock hit a record high on Monday as global vaccination programs ramped up. Last Thursday’s earning release also showed that the biotech company made $4.4 billion in revenue in the second quarter of 2021.

Read More →
Robinhood Stock Surges After Buying Spike
Plus500
Aug 05 2021

Robinhood Stock Surges After Buying Spike

Robinhood stock surged by 50% on Wednesday following last week’s IPO. The company’s shares have jumped by over 77% since beginning trading.

Read More →
Moderna to Seek FDA Approval for COVID Vaccine Use in Teens
Plus500
May 26 2021

Moderna to Seek FDA Approval for COVID Vaccine Use in Teens

On Tuesday, Moderna announced test results showing that its COVID-19 vaccine protected adolescents between the ages of 12 and 17. The vaccine could be the second approved for children in this age range.

Read More →

Why Plus500?

Understandable Platform

Competitive Spreads

Authorised and Regulated

Negative Balance Protection

24/7 Online Support

Need Help?
24/7 Support